Data Composite

Atropine Sulfate Injection Shortage

17 of 19 tracked records currently active across 8 manufacturers.

Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.

CompanyBrand nameStatusLast updated
Hospira, Inc., a Pfizer Company To Be Discontinued 11/07/2025
Hospira, Inc., a Pfizer Company To Be Discontinued 11/07/2025
Hospira, Inc., a Pfizer Company ATROPINE SULFATE Current 09/09/2026
Hikma Pharmaceuticals USA, Inc. ATROPINE SULFATE Current 09/03/2026
Amphastar Pharmaceuticals, Inc. ATROPINE SULFATE Current 09/03/2026
Accord Healthcare Inc. ATROPINE SULFATE Current 09/01/2026
American Regent, Inc. ATROPINE SULFATE Current 09/01/2026
American Regent, Inc. ATROPINE SULFATE Current 09/01/2026
Fresenius Kabi USA, LLC ATROPINE SULFATE Current 09/01/2026
Medefil, Inc. ATROPINE SULFATE Current 09/01/2026
Accord Healthcare Inc. Current 09/01/2026
Accord Healthcare Inc. Current 09/01/2026
Accord Healthcare Inc. ATROPINE SULFATE Current 09/01/2026
Accord Healthcare Inc. ATROPINE SULFATE Current 09/01/2026
Accord Healthcare Inc. ATROPINE SULFATE Current 09/01/2026
Hospira, Inc., a Pfizer Company ATROPINE SULFATE Current 08/24/2026
Somerset Therapeutics, LLC ATROPINE SULFATE Current 07/20/2026
Somerset Therapeutics, LLC ATROPINE SULFATE Current 07/20/2026
Somerset Therapeutics, LLC ATROPINE SULFATE Current 07/20/2026

← All shortages